Porton Wins CDMO Leadership Award: Global Small Molecule API

In March 2025, Porton Pharma Solutions Ltd. was honored with the "Global Small Molecule API Award" at the 14th Outsourced Pharma CDMO Leadership Awards, recognizing its exceptional end-to-end services across the global small molecule drug lifecycle. This award reaffirms Porton's outstanding performance in the CDMO sector for pharmaceutical R&D and manufacturing worldwide.

 Porton's triumph in the "Global Small Molecule API" category demonstrates its extensive capabilities in providing high-quality development and manufacturing solutions for global pharmaceutical companies, innovative drug research institutions, and academic organizations. This recognition emphasizes Porton's support for drug development from preclinical studies through to commercial manufacturing.